So sorry to see Paralympic cyclist Kadeena Cox, who has MS, crash out of her race in the women's C4-5 500m time trial. "I didn’t feel comfortable in the gate, my right side is my weak side – I just over compensated & couldn’t balance on my weaker side." metro.co.uk/2024/08/29/bri…

Results of the phase 3 HERCULES trial assessing the bruton's tyrosine kinase inhibitor tolebrutinib for multiple sclerosis will be released ECTRIMS 2024 September 18-20 in Copenhagen, Denmark medscape.com/viewarticle/10…

RIsk of MS is thought to be extremely low in Somalia, but Somali American can definitely get it. This single center (the Mayo Clinic in Rochester) reports 18 Somali Americans with MS. pubmed.ncbi.nlm.nih.gov/39213863/

When asked about the type of MS they have, patients and their providers only agree 64% of the time. Senior author Daniel Ontaneda pubmed.ncbi.nlm.nih.gov/39213839/

A recent patient of mine had undiagnosed multiple sclerosis for a prolonged period. A prior CT head showed obvious brain atrophy and subcortical low attenuating lesions, but a report of "no acute changes" fooled their internist into thinking the scan was normal,delaying referral

#BTKi on edge - #Tolebrutinib 2nd in class failing to top #Teriflunomide in relapsing #MS Hope for #SPMS but do benefits outweigh risks? Details ECTRIMS #MSCopenhagen2024 MS Society UK MSTrust the_MSBlog National MS Society Dr. Brandon Beaber Barry Singer MD 🧠 Aaron Boster MD theMSguide.com 🧠

Klaus Schmierer🎗️🇺🇦 ECTRIMS MS Society UK MSTrust the_MSBlog National MS Society Dr. Brandon Beaber Aaron Boster MD theMSguide.com 🧠 Positive results in delaying disability in non-relapsing secondary-progressive MS study is definitely a win for MS patients, especially if the effect is large. "Considerable" delay to time of onset of disability progression in relapsing MS is promising. bit.ly/4g5WHCL

Multiple Sclerosis RESEARCH BREAKTHROUGH! (Positive result in the HERCULES trial [tolebrutinb in secondary progressive multiple sclerosis]) explained by Aaron Boster MD youtu.be/oaCtzRMhHNU?si…

🥂thank you- it is a great honor for me and thank you and your family to make this possible- I look forward receiving it ECTRIMS

Tolebrutinib Effective for Secondary Progressive Multiple Sclerosis (Sanofi Press Release) youtu.be/kCN4xoVGTEE?si…

Congratulations to Prof Kerstin Hellwig for winning the Rachel Horne Prize for Women's Research in #MultipleSclerosis! Prof Hellwig is currently coordinating a Special Collection on Women's Research in Neurology. Interested in contributing? Check it out: journals.sagepub.com/topic/collecti…

As promised a link for you to download my slides from today's European Academy of Neurology Webinar on what we have learnt about MS from therapy & trials in the last 30 years => buff.ly/3Xrh7i9

Thank you ECTRIMS and all colleagues- some became friends for your congrats but also your company on this long journey- by the way I only missed 2 ectrims since my first in Stockholm 98- 2004 Vienna (birth of my daughter ) and miserably Lyon- postdoc in the US no entry visa…

The BTK inhibitor fenebrutinib in the Phase II FENopta open-label extension trial (for relapsing MS) found 96% were free of relapses, 99% were free of enhancing MRI lesions, and disability was stable over 1 year. biospace.com/press-releases…

Genetics of inherited peripheral neuropathies and the next frontier: looking backwards to progress forwards jnnp.bmj.com/content/early/…

Your baby’s all grown up! Cerebellum may mean “little brain” but its anything but little! How well do YOU know cerebellar anatomy? Do you just say “cerebellar hemisphere” & hope nobody asks? Here's the functional anatomy that you NEED to know in the cerebellum! Everyone

The spinal tap for MS diagnosis is dying. This study found the "central vein sign" (veins in the center of MS plaques on MRI) is just as accurate. Authors include Daniel Ontaneda Peter Calabresi pubmed.ncbi.nlm.nih.gov/39234802/

This is a case report of lung injury requiring ICU care caused by intravenous immunoglobin (IVIG) given to treat low antibodies and prolonged covid-19 in a 63 year old man receiving rituximab for MS. Never underestimate the risks of these treatments. pubmed.ncbi.nlm.nih.gov/39232646/

Thalamic lesions with some sparing of the posterior limb of the internal capsule can be seen in neuro-Behçet’s syndrome pubmed.ncbi.nlm.nih.gov/39230724/

Optic Neuritis Vision Loss and eye pain by Aaron Boster MD youtube.com/shorts/1FU1A-x…